Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $8.80

Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock […]

Related Keywords

Canada , , Acadian Asset Management , Jefferies Financial Group , Sg Americas Securities , Schulhoff Co , Commonwealth Equity Services , Nasdaq , Pyxis Oncology Inc , Cetera Advisors , Royal Bank , Pyxis Oncology , Get Free Report , Financial Group , Equity Services , Asset Management , Get Free , Pyxis Oncology Daily ,